Eva Marxen1, Liang Jin2, Jette Jacobsen1, Christian Janfelt1, Birgitte Hyrup3, Joseph A Nicolazzo4. 1. Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. 2. Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, VIC, Australia. 3. Fertin Pharma A/S, Vejle, Denmark. 4. Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, VIC, Australia. joseph.nicolazzo@monash.edu.
Abstract
PURPOSE: The purpose of this study was to assess the effect of several chemical permeation enhancers on the buccal permeability of nicotine and to image the spatial distribution of nicotine in buccal mucosa with and without buccal permeation enhancers. METHODS: The impact of sodium taurodeoxycholate (STDC), sodium dodecyl sulphate (SDS), dimethyl sulfoxide (DMSO) and Azone® on the permeability of [3H]-nicotine and [14C]-mannitol (a paracellular marker) across porcine buccal mucosa was studied ex vivo in modified Ussing chambers. The distribution of nicotine, mannitol and permeation enhancers was imaged using using matrix-assisted laser desorption ionization mass spectrometry imaging (MALDI MSI). RESULTS: Despite STDC significantly increasing permeability of [14C]-mannitol, no enhancing effect was seen on [3H]-nicotine permeability with any of the permeation enhancers. Rather, SDS and DMSO retarded nicotine permeability, likely due to nicotine being retained in the donor compartment. The permeability results were complemented by the spatial distribution of nicotine and mannitol determined with MALDI MSI. CONCLUSIONS: The buccal permeability of nicotine was affected in an enhancer specific manner, suggesting that nicotine primarily diffuses via the transcellular pathway. MALDI MSI was shown to complement ex vivo permeability studies and to be a useful qualitative tool for visualizing drug and penetration enhancer distribution in buccal mucosa.
PURPOSE: The purpose of this study was to assess the effect of several chemical permeation enhancers on the buccal permeability of nicotine and to image the spatial distribution of nicotine in buccal mucosa with and without buccal permeation enhancers. METHODS: The impact of sodium taurodeoxycholate (STDC), sodium dodecyl sulphate (SDS), dimethyl sulfoxide (DMSO) and Azone® on the permeability of [3H]-nicotine and [14C]-mannitol (a paracellular marker) across porcine buccal mucosa was studied ex vivo in modified Ussing chambers. The distribution of nicotine, mannitol and permeation enhancers was imaged using using matrix-assisted laser desorption ionization mass spectrometry imaging (MALDI MSI). RESULTS: Despite STDC significantly increasing permeability of [14C]-mannitol, no enhancing effect was seen on [3H]-nicotine permeability with any of the permeation enhancers. Rather, SDS and DMSOretardednicotine permeability, likely due to nicotine being retained in the donor compartment. The permeability results were complemented by the spatial distribution of nicotine and mannitol determined with MALDI MSI. CONCLUSIONS: The buccal permeability of nicotine was affected in an enhancer specific manner, suggesting that nicotine primarily diffuses via the transcellular pathway. MALDI MSI was shown to complement ex vivo permeability studies and to be a useful qualitative tool for visualizing drug and penetration enhancer distribution in buccal mucosa.
Entities:
Keywords:
buccal mucosa; mass spectrometry imaging; nicotine; permeability; permeation enhancer
Authors: Liang Jin; Ben J Boyd; Paul J White; Michael W Pennington; Raymond S Norton; Joseph A Nicolazzo Journal: J Control Release Date: 2014-12-04 Impact factor: 9.776
Authors: Longsheng Hu; Sérgio M C Silva; Bassam B Damaj; Richard Martin; Bozena B Michniak-Kohn Journal: Int J Pharm Date: 2011-09-22 Impact factor: 5.875
Authors: Guillaume Robichaud; Kenneth P Garrard; Jeremy A Barry; David C Muddiman Journal: J Am Soc Mass Spectrom Date: 2013-03-28 Impact factor: 3.109
Authors: Katharina H Clitherow; Craig Murdoch; Sebastian Guy Spain; Anna Mette Handler; Helen E Colley; Mai Bay Stie; Hanne Mørck Nielsen; Christian Janfelt; Paul V Hatton; Jette Jacobsen Journal: Mol Pharm Date: 2019-08-15 Impact factor: 4.939